Browsing Registrations from Cristin by Journals "Cancer Medicine"
Now showing items 1-6 of 6
-
The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed
(Journal article; Peer reviewed, 2022)Clofarabine is an active antileukemic drug for subgroups of patients with acute myeloid leukemia (AML). Multi-state models can provide additional insights to supplement the original intention-to-treat analysis of randomized ... -
APOBEC3A/B deletion polymorphism and endometrial cancer risk
(Journal article; Peer reviewed, 2022)Background A common 30 kb deletion affecting the APOBEC3A and APOBEC3B genes has been linked to increased APOBEC activity and APOBEC-related mutational signatures in human cancers. The role of this deletion as a cancer ... -
Losing a child to adolescent cancer: A register-based cohort study of psychotropic medication use in bereaved parents
(Journal article; Peer reviewed, 2023)Purpose To investigate the short- and long-term risk of psychotropic medication use in parents who lose a child to cancer diagnosed in adolescence. Methods This is a Swedish nationwide register-based study including ... -
Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas
(Journal article; Peer reviewed, 2023)Background: High-grade serous ovarian carcinoma (HGSOC) is the deadliest ovarian cancer subtype, and survival relates to initial cytoreductive surgical treatment. The existing tools for surgical outcome prediction remain ... -
MRI-based radiomic signatures for pretreatment prognostication in cervical cancer
(Journal article; Peer reviewed, 2023)Background Accurate pretherapeutic prognostication is important for tailoring treatment in cervical cancer (CC). Purpose To investigate whether pretreatment MRI-based radiomic signatures predict disease-specific ... -
β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma
(Journal article; Peer reviewed, 2023)Background Vascular endothelial growth factor (VEGF) was initially known as vascular permeability factor and identified as a driver of tumour angiogenesis. Recently, its role in supporting an immunosuppressive tumour ...